Frontiers in Clinical Drug Research: Anti-Infectives最新文献_第2页

Bioactive Substances as Anti-infective Strategies Against Clostridioides Difficile 生物活性物质对艰难梭菌的抗感染策略

Frontiers in Clinical Drug Research: Anti-Infectives Pub Date : 2021-07-02 DOI: 10.2174/9789814998093121070005

J. Barbosa, Paula Teixeira

引用次数: 0

Development of Antimalarial and Antileishmanial Drugs from Amazonian Biodiversity 从亚马逊生物多样性中开发抗疟疾和抗利什曼原虫药物

Frontiers in Clinical Drug Research: Anti-Infectives Pub Date : 2021-07-02 DOI: 10.2174/9789814998093121070007

A. R. Q. Gomes, K. Albuquerque, H. P. C. Brígido, Juliana Correa-Barbosa, M. Dolabela, S. Percário

引用次数: 0

Anti-Toxoplasma Drug Discovery and Natural Products: a Brief Overview 抗弓形虫药物的发现和天然产物:简要概述

Frontiers in Clinical Drug Research: Anti-Infectives Pub Date : 2021-07-02 DOI: 10.2174/9789814998093121070006

Jhony Anacleto-Santos, Perla Y. López-Camacho, E. Vega-Ávila, R. Mondragón-Flores, Elba Carrasco-Ramírez, Norma Rivera Fernández

引用次数: 0

Nucleic Acid and Peptide Aptamers as Potential Antiviral Drugs 核酸和肽适体作为潜在的抗病毒药物

Frontiers in Clinical Drug Research: Anti-Infectives Pub Date : 2021-07-02 DOI: 10.2174/9789814998093121070003

S. Evran, Ö. Uğurlu, E. Man, M. Gültan, C. Özyurt

{"title":"Nucleic Acid and Peptide Aptamers as Potential Antiviral Drugs","authors":"S. Evran, Ö. Uğurlu, E. Man, M. Gültan, C. Özyurt","doi":"10.2174/9789814998093121070003","DOIUrl":"https://doi.org/10.2174/9789814998093121070003","url":null,"abstract":"Aptamers with target-specific binding properties have emerged as an alternative to antibodies. Nucleic acid aptamers are short single-stranded oligonucleotides that can fold into unique three-dimensional structures. Nucleic acid aptamers are selected from random libraries in vitro by using the SELEX (Systematic Evolution of Ligands by Exponential Enrichment) technology. Likewise, peptide aptamers are short peptides that can be selected in vitro by using different strategies including phage display, ribosome display, or mRNA display. Aptamers are superior to antibodies with regard to ease of production, high stability, small size, and low cost. Therefore, aptamers find broad use in different biotechnological and therapeutic applications. Among them, aptamer use in virus detection and antiviral therapy is one of the attractive applications. The present Covid-19 pandemic and life-threatening viral infections reveal the need for rapid therapeutic solutions that can efficiently target viral mechanisms. In this respect, the chapter is mainly focused on aptamers with antiviral activity, as well as the use of aptamers in viral detection platforms. First, we summarize aptamer selection technologies that can be performed in vitro. Among them, we briefly explain ribosome display, mRNA display and SELEX (Systematic Evolution of Ligands by Exponential Enrichment) technologies. Then, we review aptamers targeting viral proteins and viral invasion mechanisms. In addition, we give an overview of aptamers developed against viruses. We also discuss the major hurdles in aptamer use, as well as the strategies to improve the drug potential of aptamers.","PeriodicalId":367372,"journal":{"name":"Frontiers in Clinical Drug Research: Anti-Infectives","volume":"26 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123687672","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

List of Contributors 贡献者名单

Frontiers in Clinical Drug Research: Anti-Infectives Pub Date : 2020-08-20 DOI: 10.2174/9789811425745120060002

引用次数: 0

Frontiers in Clinical Drug Research: Anti-Infectives: Volume 6 临床药物研究前沿:抗感染:第6卷

Frontiers in Clinical Drug Research: Anti-Infectives Pub Date : 2020-08-20 DOI: 10.2174/97898114257451200601

引用次数: 0